Technology News and Research

RSS

AstraZeneca Canada files a New Drug Submission (NDS) for FluMist in Canada

AstraZeneca Canada Inc. announced today that it has filed a New Drug Submission (NDS) for FluMist(R) (Influenza Vaccine, Live Attenuated Intranasal) with Health Canada.

19 Aug 2009

New tool for scientists - light used to manipulate cell movement

One of the biggest challenges in scientists' quest to develop new and better treatments for cancer is gaining a better understanding of how and why cancer spreads. Recent breakthroughs have uncovered how different cellular proteins are turned 'on' or 'off' at the molecular level, but much remains to be understood about how protein signaling influences cell behavior.

19 Aug 2009

ImmunoCellular Therapeutics to participate in the Southern California Investor Conference

ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it will participate in the Southern California Investor Conference being held in Newport Beach, CA, on Tuesday August 18, 2009.

19 Aug 2009

Omnia Biologics and Aparna Biosciences sign agreement on lentivirus drug development

Biologics contract manufacturer Omnia Biologics, Inc. (Omnia) (Rockville, MD) and drug development company Aparna Biosciences Corp. (AparnaBio) (Rockville, MD) today announced a deal for Omnia to provide AparnaBio with process development and production services. Omnia will provide lentiviral vector technical services as well as manufacture of research grade through cGMP grade materials.

19 Aug 2009

CEL-SCI expands work on current H1N1 virus vaccine

CEL-SCI Corporation has announced that it is expanding the scope of its work towards creating a novel treatment and vaccination against the current H1N1 virus, as well as a future mutated form in which the virus has acquired greater morbidity and mortality.

19 Aug 2009

New "micropatterning" method useful in gene expression studies

Like oil and water, two water-based liquids can mingle without mixing in a new University of Michigan technology developed for biological experiments.

19 Aug 2009

Light-activated delivery system enhances anti-tumour drug potency

The effects of tumour-targeting drugs in mice are significantly enhanced by PCI Biotech's light-activated delivery system, a new study shows. Researchers say this dual therapy approach could be employed to increase the effect and lower the side effects of anti-cancer drugs in humans.

19 Aug 2009

New data show nanotechnology-related activities in every U.S. state

Every state can now lay claim to the nanotechnology revolution. Data released today by the Project on Emerging Nanotechnologies (PEN) highlights more than 1,200 companies, universities, government laboratories, and other organizations across all 50 U.S. states and in the District of Columbia that are involved in nanotechnology research, development, and commercialization. This number is up 50 percent from the 800 organizations identified just two years ago.

19 Aug 2009

HealthHelp upgrades customer care technology with Qwest solutions

HealthHelp, a Houston-based radiology benefit-management company, recently upgraded its customer care technology with Qwest services. Now, physician offices can operate more efficiently with self-service, around-the-clock voice and data access to HealthHelp’s radiology benefit-management programs thanks to technology powered by Qwest Communications.

19 Aug 2009

Novavax reports positive preclinical results for H1N1 influenza VLP vaccine

Novavax, Inc. (Nasdaq: NVAX) announced positive preclinical results with Novavax's 2009 novel H1N1 influenza virus-like particle (VLP) vaccine. The study, conducted by scientists from Novavax and the Centers for Disease Control and Prevention (CDC) based in Atlanta, GA, under a collaborative agreement, represents the first efficacy report of a 2009 novel H1N1 vaccine in ferrets. The ferret model is widely accepted to be the most appropriate animal model for evaluating influenza disease and vaccines. Novavax scientists designed the vaccine using recombinant virus like particles (VLP) technology against an H1N1 virus strain (A/California/04/2009) isolated in the beginning of the 2009 H1N1 outbreak.

19 Aug 2009

Bioheart's executive management team strengthened by the inclusion of board members

Bioheart, Inc., (OTC Bulletin Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and other cardiovascular diseases announced today that several of its Directors have joined the Company's executive management team. In addition to assuming the position of Chairman of the Company's Board of Directors, Karl E. Groth, Ph.D., became the Chief Executive Officer; Peggy A. Farley became Chief Operating Officer; and Mark P. Borman became Chief Financial Officer. Howard Leonhardt will continue as Chief Scientific and Technology Officer, and Chairman of the Scientific Advisory Board. Mr. Leonhardt, the Company's founder, thus will be able to focus on enhancing the Company's existing technologies and strengthening its position as the leader within the cardiovascular arena of the stem cell therapy industry.

19 Aug 2009

Orient Pharma granted commercialization rights for a drug candidate by DURECT

DURECT Corporation today announced that it has signed a development and license agreement with Orient Pharma Co., Ltd., a diversified multinational pharmaceutical, healthcare and consumer products company with headquarters in Taiwan, under which DURECT has granted to Orient Pharma development and commercialization rights in selected Asian and South Pacific countries to a drug candidate based on DURECT's ORADUR(R) Technology and one specified active pharmaceutical ingredient for the treatment of attention deficit hyperactivity disorder (ADHD).

19 Aug 2009

Solta Medical launches new Thermage Comfort Pulse Technology system

Solta Medical, Inc. (Nasdaq: SLTM) today announced the launch of its new Thermage CPT(TM) system, representing a significant leap forward in skin tightening and body contouring technology. The Thermage CPT system incorporates proprietary Comfort Pulse Technology(TM) in every aspect of the system including a new ergonomic vibrating hand piece and scientifically advanced Face Tip 3.0 and Body Tip 16.0 treatment tips.

19 Aug 2009

Siemens Healthcare's SOMATOM Emotion 16 ranked highest among 16-slice CT systems

According to a recent report from market research firm KLAS*, Siemens Healthcare's SOMATOM(R) Emotion CT scanner is ranked highest among 16-slice CT systems. Powerful and cost-effective, the SOMATOM Emotion 16 enables facilities to not only perform routine examinations, such as brain, chest, and abdomen examinations, but also undertake high-end, detailed examinations, such as high-resolution CT angiography, which greatly improve patient care, as well as diagnostic workflow.

19 Aug 2009

US Spine awarded patent for Facet Fixation System

US Spine® announced today that it has been awarded the first patent in a series for its Facet Fixation System. The United States Patent and Trademark Office has assigned patent number 7,563,275 to the Facet Fixation System. US Spine began commercial launch of the system in 2008, which features the Facet Gun™ and Facet Bolt®.

19 Aug 2009

Brooks Rehabilitation's new specialty clinic to provide advanced treatments for back and neck

Brooks Rehabilitation's newest specialty clinic, the Brooks Center for Back & Neck Health, offers patients advanced treatments for both acute and chronic conditions of the spine, including whiplash, lumbar stenosis, cervical or lumbar radiculopathy, cervical or lumbar instability, sciatica, TMJ, osteoarthritis, degenerative disc disease, and more. According to the National Institutes of Health, back pain is the second most common reason Americans go to the doctor (headaches are the first), and among the most common reasons for surgery. Research has demonstrated the effectiveness of physical therapy for affecting outcomes in patients with spinal conditions.

19 Aug 2009

Young innovators Andrea Armani and Ellis Meng to feature in Technology Review magazine's 2009 TR35 list

The University of Southern California today announced that two faculty members from the USC Viterbi School of Engineering have been recognized by Technology Review magazine as some of the world's top innovators under the age of 35. Andrea Armani, Assistant Professor of Chemical Engineering and Materials Science, and Ellis Meng, Assistant Professor of Biomedical Engineering, will both appear on the prestigious 2009 TR35 list.

19 Aug 2009

Aerocrine allowed to add a third patent to its infringment complaint against Apieron

Aerocrine AB today announced that the United States District Court has accepted Aerocrine’s motion for leave to add a third patent to its October 2008 patent infringement complaint against Apieron, Inc. Menlow Park, USA.

19 Aug 2009

New production technology to develop vaccine for norovirus

Scientists have used a new vaccine production technology to develop a vaccine for norovirus, a dreaded cause of diarrhea and vomiting that may be the second most common viral infection in the United States after the flu. Sometimes called the "cruise ship virus," this microbe can spread like wildfire through passenger liners, schools, offices and military bases.

19 Aug 2009

The iPosture now available in UK

The iPosture, a posture improvement device developed by Memphis-based neurologist Moacir Schnapp, M.D., is now available for purchase in the United Kingdom via iPosture Direct.

19 Aug 2009

Technology News and Research

AstraZeneca Canada files a New Drug Submission (NDS) for FluMist in Canada

New tool for scientists - light used to manipulate cell movement

ImmunoCellular Therapeutics to participate in the Southern California Investor Conference

Omnia Biologics and Aparna Biosciences sign agreement on lentivirus drug development

CEL-SCI expands work on current H1N1 virus vaccine

New "micropatterning" method useful in gene expression studies

Light-activated delivery system enhances anti-tumour drug potency

New data show nanotechnology-related activities in every U.S. state

HealthHelp upgrades customer care technology with Qwest solutions

Novavax reports positive preclinical results for H1N1 influenza VLP vaccine

Bioheart's executive management team strengthened by the inclusion of board members

Orient Pharma granted commercialization rights for a drug candidate by DURECT

Solta Medical launches new Thermage Comfort Pulse Technology system

Siemens Healthcare's SOMATOM Emotion 16 ranked highest among 16-slice CT systems

US Spine awarded patent for Facet Fixation System

Brooks Rehabilitation's new specialty clinic to provide advanced treatments for back and neck

Young innovators Andrea Armani and Ellis Meng to feature in Technology Review magazine's 2009 TR35 list

Aerocrine allowed to add a third patent to its infringment complaint against Apieron

New production technology to develop vaccine for norovirus

The iPosture now available in UK

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News